Literature DB >> 7436100

Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure.

O Vizcaino, D E Corrier, M K Terry, C A Carson, A J Lee, K L Kuttler, M Ristic, G S Treviño.   

Abstract

The efficacy of three immunization methods for bovine anaplasmosis was tested on 88 yearling Normandy cattle which were challenge-exposed under field conditions in an enzootic zone in Colombia, South American. A total of 30 cattle were immunized (premunized) with a presumed mild Colombian isolate of Anaplasma marginale; 29 calves were vaccinated with an attenuated A marginale of ovine origin; and 29 were exposed to a virulent A marginale stabilate of Colombian origin. Twenty-nine nonvaccinated cattle served as controls. Parasitemia, packed cell volume, body weight, and complement-fixation antibody response were monitored to determine host response to challenge exposure. The calves experienced a Babesia challenge exposure following arrival in the enzootic zone, after which a transient increase in Anaplasma parasitemia, accompanied by a decrease in packed cell volume, occurred in most of the vaccinated calves. However, neither clinical anaplasmosis nor mortality due to the disease occurred in the immunized cattle. Twenty-seven of the nonvaccinated calves had signs of clinical anaplasmosis and five (17%) died of the disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436100

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  Crossprotective immunity between the Florida and a Zimbabwe stock of Anaplasma marginale.

Authors:  N Tebele; G H Palmer
Journal:  Trop Anim Health Prod       Date:  1991-11       Impact factor: 1.559

2.  Immunization of cattle with the MSP-1 surface protein complex induces protection against a structurally variant Anaplasma marginale isolate.

Authors:  G H Palmer; A F Barbet; G H Cantor; T C McGuire
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Efficacy of purified Anaplasma marginale initial bodies as a vaccine against anaplasmosis.

Authors:  S Montenegro-James; M A James; M T Benitez; E Leon; B K Baek; A T Guillen
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

4.  Molecular size variations in an immunoprotective protein complex among isolates of Anaplasma marginale.

Authors:  S M Oberle; G H Palmer; A F Barbet; T C McGuire
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

5.  Characteristics of an attenuated Anaplasma marginale of deer origin as an anaplasmosis vaccine.

Authors:  K L Kuttler; J L Zaugg
Journal:  Trop Anim Health Prod       Date:  1988-05       Impact factor: 1.559

6.  Intermolecular relationships of major surface proteins of Anaplasma marginale.

Authors:  M C Vidotto; T C McGuire; T F McElwain; G H Palmer; D P Knowles
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

Review 7.  Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach.

Authors:  Rosa Estela Quiroz-Castañeda; Itzel Amaro-Estrada; Sergio Darío Rodríguez-Camarillo
Journal:  Biomed Res Int       Date:  2016-08-17       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.